Document is current
Any future updates will be listed below
-
Authors
Lin, Dee
Pilon, Dominic https://orcid.org/0000-0002-0778-9564
Morrison, Laura
Shah, Aditi
Lafeuille, Marie-Hélène
Lefebvre, Patrick
Benson, Carmela
-
Funding
Funding for this research was provided by:
Janssen Scientific Affairs, LLC
- License Information
-
More Information
Article History
Accepted: 14 May 2023
First Online: 8 June 2023
Declarations
:
: This study was supported by Janssen Scientific Affairs, LLC.
: DP, LM, AS, MHL, and PL are employees of Analysis Group, Inc., a consulting company that has provided paid consulting services to Janssen Scientific Affairs, LLC., which funded the development and conduct of this study and manuscript. DL and CB are employees of Janssen Scientific Affairs, LLC. and stockholders of Johnson & Johnson.
: The data used were de-identified and comply with the patient requirements of the Health Insurance Portability and Accountability Act, therefore no institutional review board exemption was needed.
: Not applicable since patient data were de-identified.
: Not applicable since patient data were de-identified.
: The data that support the findings of this study are available from IBM<sup>®</sup> MarketScan<sup>®</sup>, but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Any researchers interested in obtaining the data used in this study can access the database through IBM<sup>®</sup>, under a license agreement, including the payment of appropriate license fee.
: All analyses were conducted using SAS Enterprise Guide 7.1 (SAS Institute, Cary, NC). The SAS programs are proprietary materials of Analysis Group, Inc.; therefore, restrictions apply to the access of these codes, which cannot be made available publicly.
: DL, DP, LM, AS, MHL, PL, and CB made substantial contributions to the conception and design of the study, acquisition, analysis and interpretation of data, acknowledgment of drafting the article, and revising it critically for important intellectual content. All authors have provided their final approval of the manuscript to be published and agree to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
: Part of the material in this manuscript has been presented at the Virtual International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 2021 Annual Meeting, 17–20 May 2021.
